Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

James Cropper loses 'significant merchant customer'

(Sharecast News) - Paper and packaging business James Cropper warned on Monday that it had received notice that "a significant merchant customer" will no longer source certain coloured paper ranges from it, effective immediately. James Cropper said this decision followed a reduction of approximately 50% in sales of these products to that customer in Q1. However, James Cropper said that with a revised strategy and operating plan already established in its paper and packaging division, provisional Q1 results showed that the unit would be trading ahead of both expectations and prior-year comparators if not for the loss of the merchant customer.

The London-listed firm said its Q1 performance was driven by business with other customers and efficiency savings pursuant to its revised operating approach. It now expects the paper and packaging business to report "a significant improvement" in adjusted underlying earnings in FY26. Revenues in its advanced materials business grew by approximately 10% in Q1.

James Cropper added that overall, it was confident that it will deliver "significant growth" in adjusted EBITDA profitability in FY26 against FY25.

Chief executive David Stirling said: "While we are disappointed by the customer's unexpected decision, the board is encouraged by early progress delivered by the strategy outlined at the company's Capital Markets Event on 18 June 2025. Performance in the paper and packaging business is improving and is expected to continue to do so, as it is for the overall group.

"James Cropper has a heritage of 180 years as a papermaker and a leading reputation in the manufacture and supply of coloured papers for over 150 years to both UK and international markets, and remains committed to this segment. The company will continue to supply such coloured paper products through existing and alternative channels."

As of 0940 BST, James Cropper shares were down 5.0% at 209.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.